#idtbiologika — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #idtbiologika, aggregated by home.social.
-
SK Bioscience strengthens production cooperation with subsidiary IDT Biologika for second-generation Zaire Ebola vaccine development with MSD, expanding its global vaccine production network to address infectious disease outbreaks in Africa including Democratic Republic of Congo.
#YonhapInfomax #SKBioscience #EbolaVaccine #MSD #IDTBiologika #ContractManufacturing #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=111388 -
SK Bioscience strengthens production cooperation with subsidiary IDT Biologika for second-generation Zaire Ebola vaccine development with MSD, expanding its global vaccine production network to address infectious disease outbreaks in Africa including Democratic Republic of Congo.
#YonhapInfomax #SKBioscience #EbolaVaccine #MSD #IDTBiologika #ContractManufacturing #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=111388 -
SK Bioscience strengthens production cooperation with subsidiary IDT Biologika for second-generation Zaire Ebola vaccine development with MSD, expanding its global vaccine production network to address infectious disease outbreaks in Africa including Democratic Republic of Congo.
#YonhapInfomax #SKBioscience #EbolaVaccine #MSD #IDTBiologika #ContractManufacturing #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=111388 -
SK Bioscience strengthens production cooperation with subsidiary IDT Biologika for second-generation Zaire Ebola vaccine development with MSD, expanding its global vaccine production network to address infectious disease outbreaks in Africa including Democratic Republic of Congo.
#YonhapInfomax #SKBioscience #EbolaVaccine #MSD #IDTBiologika #ContractManufacturing #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=111388 -
SK Bioscience reports Q1 operating loss of 15.1 billion won, outperforming market expectations, with sales surge of 594% year-on-year driven by IDT Biologika acquisition and strong vaccine sales
#YonhapInfomax #SKBioscience #Q1Earnings #OperatingLoss #VaccineSales #IDTBiologika #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=61992 -
SK Bioscience forecasts 3-5 years of losses due to growth investments, emphasizing sufficient IPO funds and ruling out external financing plans amid market skepticism over cash flow stability.
#YonhapInfomax #SKBioscience #InvestmentLosses #VaccineProduction #CashFlow #IDTBiologika #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60340 -
SK Bioscience forecasts 3-5 years of losses due to growth investments, emphasizing sufficient IPO funds and ruling out external financing plans amid market skepticism over cash flow stability.
#YonhapInfomax #SKBioscience #InvestmentLosses #VaccineProduction #CashFlow #IDTBiologika #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60340 -
SK Bioscience forecasts 3-5 years of losses due to growth investments, emphasizing sufficient IPO funds and ruling out external financing plans amid market skepticism over cash flow stability.
#YonhapInfomax #SKBioscience #InvestmentLosses #VaccineProduction #CashFlow #IDTBiologika #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60340 -
SK Bioscience forecasts 3-5 years of losses due to growth investments, emphasizing sufficient IPO funds and ruling out external financing plans amid market skepticism over cash flow stability.
#YonhapInfomax #SKBioscience #InvestmentLosses #VaccineProduction #CashFlow #IDTBiologika #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60340 -
SK Bioscience forecasts 3-5 years of losses due to growth investments, emphasizing sufficient IPO funds and ruling out external financing plans amid market skepticism over cash flow stability.
#YonhapInfomax #SKBioscience #InvestmentLosses #VaccineProduction #CashFlow #IDTBiologika #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60340 -
Deutschland hat sich binnen weniger Monate zu einem der zentralen Produktionsländer für Corona-Impfstoffe entwickelt. Das neue BioNTech-Werk in Marburg ist erst der Anfang.
Deutschland will Impfstoff-Produktion ausbauen | DW | 03.04.2021 #Corona #Coronavirus #Corona-Pandemie #COVID-19 #Impfungen #Impfstoffe #Deutschland #BioNTech #Curevac #AstraZeneca #Johnson&Johnson #IDTBiologika -
Eine ostdeutsche Firma ist in Gesprächen, um Russlands Impfstoff Sputnik V zu produzieren. Die Politik will das unterstützen, doch die Firma selbst gibt sich vorsichtig.
Russischer Corona-Impfstoff bald aus Dessau? | DW | 05.02.2021 #Corona #Impfstoff #SputnikV #Russland #IDTBiologika